218 related articles for article (PubMed ID: 25403292)
21. Lung disease associated with the IVS8 5T allele of the CFTR gene.
Noone PG; Pue CA; Zhou Z; Friedman KJ; Wakeling EL; Ganeshananthan M; Simon RH; Silverman LM; Knowles MR
Am J Respir Crit Care Med; 2000 Nov; 162(5):1919-24. PubMed ID: 11069835
[TBL] [Abstract][Full Text] [Related]
22. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA.
Chu CS; Trapnell BC; Curristin S; Cutting GR; Crystal RG
Nat Genet; 1993 Feb; 3(2):151-6. PubMed ID: 7684646
[TBL] [Abstract][Full Text] [Related]
23. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.
Cuppens H; Lin W; Jaspers M; Costes B; Teng H; Vankeerberghen A; Jorissen M; Droogmans G; Reynaert I; Goossens M; Nilius B; Cassiman JJ
J Clin Invest; 1998 Jan; 101(2):487-96. PubMed ID: 9435322
[TBL] [Abstract][Full Text] [Related]
24. Two CFTR mutations within codon 970 differently impact on the chloride channel functionality.
Amato F; Scudieri P; Musante I; Tomati V; Caci E; Comegna M; Maietta S; Manzoni F; Di Lullo AM; De Wachter E; Vanderhelst E; Terlizzi V; Braggion C; Castaldo G; Galietta LJV
Hum Mutat; 2019 Jun; 40(6):742-748. PubMed ID: 30851139
[TBL] [Abstract][Full Text] [Related]
25. In cellulo analyses of the p.Val322Ala mutation on the CFTR protein conformation and activity.
Farhat R; El-Seedy A; Sari AIP; Norez C; Pasquet MC; Becq F; Kitzis A; Ladevèze V
C R Biol; 2017 Aug; 340(8):367-371. PubMed ID: 28784578
[TBL] [Abstract][Full Text] [Related]
26. Abnormal mRNA splicing resulting from three different mutations in the CFTR gene.
Hull J; Shackleton S; Harris A
Hum Mol Genet; 1993 Jun; 2(6):689-92. PubMed ID: 7689009
[TBL] [Abstract][Full Text] [Related]
27. Large deletions in the CFTR gene: clinics and genetics in Swiss patients with CF.
Schneider M; Hirt C; Casaulta C; Barben J; Spinas R; Bühlmann U; Spalinger J; Schwizer B; Chevalier-Porst F; Gallati S
Clin Genet; 2007 Jul; 72(1):30-8. PubMed ID: 17594397
[TBL] [Abstract][Full Text] [Related]
28. Cystic fibrosis: genotypic and phenotypic variations.
Zielenski J; Tsui LC
Annu Rev Genet; 1995; 29():777-807. PubMed ID: 8825494
[TBL] [Abstract][Full Text] [Related]
29. Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.
Costantino L; Rusconi D; Soldà G; Seia M; Paracchini V; Porcaro L; Asselta R; Colombo C; Duga S
Am J Respir Cell Mol Biol; 2013 May; 48(5):619-25. PubMed ID: 23349053
[TBL] [Abstract][Full Text] [Related]
30. A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.
Will K; Dörk T; Stuhrmann M; Meitinger T; Bertele-Harms R; Tümmler B; Schmidtke J
J Clin Invest; 1994 Apr; 93(4):1852-9. PubMed ID: 7512993
[TBL] [Abstract][Full Text] [Related]
31. Identification of a splice site mutation (2789 +5 G > A) associated with small amounts of normal CFTR mRNA and mild cystic fibrosis.
Highsmith WE; Burch LH; Zhou Z; Olsen JC; Strong TV; Smith T; Friedman KJ; Silverman LM; Boucher RC; Collins FS; Knowles MR
Hum Mutat; 1997; 9(4):332-8. PubMed ID: 9101293
[TBL] [Abstract][Full Text] [Related]
32. A 32-bp deletion (2991del32) in the cystic fibrosis gene associated with CFTR mRNA reduction.
Dörk T; Will K; Grade K; Krawczak M; Tümmler B
Hum Mutat; 1994; 4(1):65-70. PubMed ID: 7524915
[TBL] [Abstract][Full Text] [Related]
33. Two novel and correlated CF-causing insertions in the (TG)mTn tract of the CFTR gene.
Pierandrei S; Blaconà G; Fabrizzi B; Cimino G; Cirilli N; Caporelli N; Angeloni A; Cipolli M; Lucarelli M
PLoS One; 2019; 14(10):e0222838. PubMed ID: 31593572
[TBL] [Abstract][Full Text] [Related]
34. Novel cause of hereditary obstructive azoospermia: a T2 allele in the CFTR gene.
Radpour R; Taherzadeh-Fard E; Gourabi H; Aslani S; Vosough Dizaj A; Aslani A
Reprod Biomed Online; 2009 Mar; 18(3):327-32. PubMed ID: 19298730
[TBL] [Abstract][Full Text] [Related]
35. Skipping of exon 9 of human CFTR in YAC-transgenic mice.
Manson A; Huxley C
Genomics; 2001 Oct; 77(3):127-34. PubMed ID: 11597137
[TBL] [Abstract][Full Text] [Related]
36. Novel mutation c.1210-3C > G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis.
Zhao X; Liu K; Xu W; Xiao M; Zhang Q; Song J; Chen K; Liu Y; Tian X; Xu KF; Zhang X
Front Med; 2022 Feb; 16(1):150-155. PubMed ID: 34302615
[TBL] [Abstract][Full Text] [Related]
37. Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis.
Straniero L; Soldà G; Costantino L; Seia M; Melotti P; Colombo C; Asselta R; Duga S
J Hum Genet; 2016 Dec; 61(12):977-984. PubMed ID: 27488443
[TBL] [Abstract][Full Text] [Related]
38. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
[TBL] [Abstract][Full Text] [Related]
39. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism.
D'Apice MR; Gambardella S; Russo S; Lucidi V; Nardone AM; Pietropolli A; Novelli G
Prenat Diagn; 2004 Dec; 24(12):981-3. PubMed ID: 15614862
[TBL] [Abstract][Full Text] [Related]
40. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
